<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1371/journal.pone.0222428</article-id><article-id pub-id-type="publisher-id">PONE-D-19-14038</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Paramyxoviruses</subject><subj-group><subject>Measles Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Paramyxoviruses</subject><subj-group><subject>Measles Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Paramyxoviruses</subject><subj-group><subject>Measles Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Paramyxoviruses</subject><subj-group><subject>Measles Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Africa</subject><subj-group><subject>Cameroon</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Evolutionary Biology</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject><subj-group><subject>Phylogenetic Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Taxonomy</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject><subj-group><subject>Phylogenetic Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Computer and Information Sciences</subject><subj-group><subject>Data Management</subject><subj-group><subject>Taxonomy</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject><subj-group><subject>Phylogenetic Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Measles</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Infectious Disease Control</subject><subj-group><subject>Vaccines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Artificial Gene Amplification and Extension</subject><subj-group><subject>Polymerase Chain Reaction</subject><subj-group><subject>Reverse Transcriptase-Polymerase Chain Reaction</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Artificial Gene Amplification and Extension</subject><subj-group><subject>Polymerase Chain Reaction</subject><subj-group><subject>Reverse Transcriptase-Polymerase Chain Reaction</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Extraction techniques</subject><subj-group><subject>RNA extraction</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Genotyping</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Genotyping</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Molecular characterization of measles virus strains circulating in Cameroon during the 2013-2016 epidemics</article-title><alt-title alt-title-type="running-head">Molecular characterization of measles virus strains circulating in Cameroon</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Obam Mekanda</surname><given-names>Franck-Martin</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Monamele</surname><given-names>Chavely Gwladys</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Simo Nemg</surname><given-names>Fr&#x000e9;dy Brice</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yonga</surname><given-names>Gilde Martial</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ouapi</surname><given-names>Diane</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Penlap Beng</surname><given-names>V&#x000e9;ronique</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bat&#x000e9;jat</surname><given-names>Christophe</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Caro</surname><given-names>Val&#x000e9;rie</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Manuguerra</surname><given-names>Jean-Claude</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9275-0874</contrib-id><name><surname>Demanou</surname><given-names>Maurice</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>WHO National Measles Reference Laboratory, Department of Virology, Centre Pasteur of Cameroon (CPC), Yaound&#x000e9;, Centre, Cameroon</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Faculty of Science, University of Yaound&#x000e9; 1, Yaound&#x000e9;, Centre, Cameroon</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Cellule d&#x02019;Intervention Biologique d&#x02019;Urgence (CIBU), Unit&#x000e9; de Recherche et d&#x02019;Expertise &#x02018;Environnement et Risques Infectieux&#x02019; (ERI), Institut Pasteur, Paris, France</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Ciccozzi</surname><given-names>Massimo</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>university of campus biomedico, ITALY</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>demanou@pasteur-yaounde.org</email></corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>9</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>14</volume><issue>9</issue><elocation-id>e0222428</elocation-id><history><date date-type="received"><day>17</day><month>5</month><year>2019</year></date><date date-type="accepted"><day>28</day><month>8</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 Obam Mekanda et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Obam Mekanda et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0222428.pdf"/><abstract><p>The first genotyping data on measles virus (MeV) strains in Cameroon dates from 1994, while other studies were realized in 2001 and 2011 with the establishment of MeV virological surveillance. However, the genetic data of MeV strains circulating in Cameroon remains fragmented and concentrated in certain regions, hence the need for an update. The objective of this study was to have recent data on MeV genotypes circulating in Cameroon. Ninety throat swabs collected during recent measles outbreaks were analyzed by MeV genotyping RT-PCR using the nucleoprotein gene N. The resulting sequences were analyzed on the basis of 450 nucleotides with MEGA 7 software. Overall genome analysis was performed on 40/90 sequences. The strains were from all ten regions and all belonged to cluster 1 of genotype B3. The genotype B3 has been circulating in Cameroon for long periods of time; efforts must be made in immunization for its elimination.</p></abstract><funding-group><funding-statement>The authors received no specific funding for this work.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="1"/><page-count count="10"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Measles is a highly contagious and potentially fatal viral infection of the child and young adult caused by measles virus (MeV): a 15.9 kb enveloped, non-segmented, negative-stranded RNA virus belonging to the <italic>Paramyxoviridae</italic> family and the <italic>Morbillivirus</italic> genus [<xref rid="pone.0222428.ref001" ref-type="bibr">1</xref>]. This virus is transmitted from human to human via sputum and droplets from the respiratory tract [<xref rid="pone.0222428.ref002" ref-type="bibr">2</xref>].</p><p>Clinically a person is declared a suspect case of measles when he has a generalized maculopapular rash and fever, with cough and/or coryza, and/or conjunctivitis [<xref rid="pone.0222428.ref003" ref-type="bibr">3</xref>]. Once the disease progresses, the immunosuppression caused by measles virus (MeV) exposes the patient to bacterial super infections causing otitis media, pneumonia, or gastrointestinal infections. The main cause of measles-related morbidity and mortality is due to association of these symptoms with other factors such as malnutrition and vitamin A deficiency [<xref rid="pone.0222428.ref004" ref-type="bibr">4</xref>].</p><p>Before the introduction of measles immunization in the 1960s, almost everyone contracted measles usually during childhood with an estimated annual incidence of 130 million cases and an early mortality of 2.5 million each year. Since the introduction of the vaccine, the incidence of measles as well as the associated early mortality rate decreased. From 2000 to 2016, a 84% drop in mortality was noted from about 550,100 to 89,780 deaths, global annual reported incidence decreased by about 87% from 145 to 19 cases per million persons, estimates of the first dose of measles-containing vaccine (MCV1) coverage increased globally from 72% to 85% and the number of countries providing second dose of measles-containing vaccine (MCV2) nationally through routine services increased from 98 (51%) to 164 (85%) in which 24 African countries [<xref rid="pone.0222428.ref005" ref-type="bibr">5</xref>]. Despite this progress, epidemics have continued in some regions. In 2016, of the 89,780 deaths attributed to measles, 85% occurred in Africa and Asia [<xref rid="pone.0222428.ref005" ref-type="bibr">5</xref>].</p><p>To date, some countries where measles has been declared eliminated have confirmed new cases in recent years, such as, South Korea with 107 new cases, of which 04 imported in 2013 [<xref rid="pone.0222428.ref006" ref-type="bibr">6</xref>]. The WHO European Region which was already close to eliminating measles confirmed a total of 21,315 cases between 2016 and 2017 with 35 deaths [<xref rid="pone.0222428.ref007" ref-type="bibr">7</xref>]. Measles remains a global public health problem hence the need to strengthen immunization, surveillance and health monitoring.</p><p>The MeV is monotypic, but the genetic variability of the genes encoding the viral hemagglutinin (H) and the nucleoprotein (N) makes it possible to be genetically characterized in 8 clades (A-H) and 24 genotypes (A, B1-B3, C1- C2, D1-D11, E, F, G1-G3, H1-H2) [<xref rid="pone.0222428.ref008" ref-type="bibr">8</xref>]. Genotype B3 endemic in several African countries can be further divided into 3 clusters (B3.1, B3.2, and B3.3) [<xref rid="pone.0222428.ref009" ref-type="bibr">9</xref>].</p><p>As part of strategic plan for measles control and elimination, the World Health Organization (WHO) has recommended that member states implement virological surveillance for circulating MeV strains [<xref rid="pone.0222428.ref010" ref-type="bibr">10</xref>]. Molecular characterization of strains is a key tool in the study of measles transmission pathways, evaluation of endemic measles eradication and indirect evaluation of the vaccination system in place [<xref rid="pone.0222428.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0222428.ref012" ref-type="bibr">12</xref>]. When high quality surveillance system associated with absence of endemic MeV transmission exist in certain region or defined geographic area for &#x02265;12 months of period of time, measles can be decleared eliminated in this area or region [<xref rid="pone.0222428.ref013" ref-type="bibr">13</xref>].</p><p>The latest genetic data on MeV strains circulating in Cameroon have been known since 1994 [<xref rid="pone.0222428.ref014" ref-type="bibr">14</xref>] and were updated in 2001 [<xref rid="pone.0222428.ref015" ref-type="bibr">15</xref>] and 2011 [<xref rid="pone.0222428.ref016" ref-type="bibr">16</xref>], however they remain fragmented and are relatively old. The aim of this study was to update the MeV strains circulating in Cameroon. These results will enable to establish a genetic basis of virological surveillance in Cameroon and evaluate the country&#x02019;s efforts to eradicate this disease.</p></sec><sec id="sec002"><title>Material and methods</title><sec id="sec003"><title>Ethics statement</title><p>This study was carried out as part of measles surveillance in Cameroon at Centre Pasteur of Cameroon (CPC), the National Reference Laboratory (NRL) for measles since 2011. There was thus no need for an ethical clearance. However, all participants read an information notice and gave a verbal consent before enrollment and sample collection.</p></sec><sec id="sec004"><title>Clinical samples</title><p>Ninety (90) throat swabs collected during the 2013, 2014, 2015 and 2016 measles outbreaks were collected by the surveillance team of the Expanded Program on Immunization (EPI) and transported to the NRL while respecting the cold chain. Once in the laboratory, samples were stored at -20 &#x000b0;C prior to analyses.</p></sec><sec id="sec005"><title>Laboratory methods</title><p>RNAs were extracted directly from the swabs using the QIAamp Viral RNA Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer&#x02019;s instructions. RNA extracts were then analyzed by MeV genotyping RT-PCR in search of 634 nucleotides of the N-gene with forward primer MeV214 (<monospace>5'-TAACAATGATGGAGAGGGTAGG-3'</monospace>) and reverse primer MeV216 (<monospace>5'-TGGAGCTATGCCATGG GAGT-3'</monospace>). The SuperScript<sup>&#x02122;</sup> III one-step system with PlatinumW Taq High Fidelity enzyme was used for amplification of the target gene fragment. The RT-PCR mixture was composed of 17 &#x003bc;l DNAse/RNAse-free water, 25 &#x003bc;l of 2X buffer, 1 &#x003bc;l of MeV214 primer, 1 &#x003bc;l of MeV216 primer, 1 &#x003bc;l of the enzyme, and 5&#x003bc;l of the RNA extract. RT-PCR was programmed for 40 cycles including a reverse transcription step of 30 minutes at 50&#x000b0;C and 15 minutes at 95&#x000b0;C, a denaturation step of 30 seconds at 94&#x000b0;C, primers hybridization of 30 second at 55&#x000b0;C, an initial elongation of one minute at 72&#x000b0;C, a final elongation of 10 minutes at 72&#x000b0;C and storage at 4&#x000b0;C. The RT-PCR products were revealed by 1% agarose gel electrophoresis after 30 minutes migration for 250 volts. All RT-PCR positive products were sequenced using the MeV214 and MeV216 primers and the resulting sequences were edited and assembled into a single consensus using the CLC Mainworkbench 5.5 software.</p></sec><sec id="sec006"><title>Phylogenetic analyses</title><p>Phylogenetic analyses were performed on 450 nucleotides of the N gene according to WHO recommendations for measles virus strains genotyping [<xref rid="pone.0222428.ref017" ref-type="bibr">17</xref>]. All consensus sequences obtained from the CLC Mainworkbench 5.5 software were first aligned with the 26 reference sequences and subsequently by 11 other sequences of genotype B3 available in GenBank using the Clustal W algorithm in MEGA 7 software. The best fit-model of nucleotide substitution was selected in MEGA 7 and was found to be the Kimura two-parameter gamma model among 24 different nucleotide substitution models. Phylogenetic trees were generated with the Maximum likelihood algorithm using Kimura two-parameter distance model in MEGA 7. Evolutionary rates among sites were modeled using the Gamma distribution and the attribution of clades, genotypes and clusters was based on the clusters formed between the studied sequences and the reference sequences of known clades. All sequences obtained in this study were named according to the WHO recommendations and submitted to Measles Nucleotide Surveillance (MeaNS) and GenBank under accession number MH255950 to MH255989.</p></sec></sec><sec sec-type="results" id="sec007"><title>Results</title><p>Overall, 41 of 90 samples (45.55%) were RT-PCR positive for the genotyping assay and 40 of these sequences could be used for phylogenetic analyses. <xref rid="pone.0222428.t001" ref-type="table">Table 1</xref> summarizes the sociodemographic data of the subjects from which the sequenced samples were obtained. All strains were collected from 2013 through 2016: 08 in 2013, 20 in 2014, 05 in 2015 and 07 for 2016. The average age of the affected subjects was 8.6 years with extremes of 7 months and 20 years, the majority of viruses were obtained from children under 10 years of age with a predominance of those aged 7 months to 5 years (29/40). The male sex was the most predominant gendre (27/40) and 08 (20%) patients had a history of vaccination against measles.</p><table-wrap id="pone.0222428.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0222428.t001</object-id><label>Table 1</label><caption><title>Characteristics of patients in whom MeV strains were collected in Cameroon from 2013 to 2016.</title></caption><alternatives><graphic id="pone.0222428.t001g" xlink:href="pone.0222428.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Genbank number</th><th align="center" rowspan="1" colspan="1">Strain name</th><th align="center" rowspan="1" colspan="1">Patient age (months)</th><th align="left" rowspan="1" colspan="1">Sex</th><th align="center" rowspan="1" colspan="1">Patient location<break/>(Region-District)</th><th align="center" rowspan="1" colspan="1">Last immunization date</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1"><bold>MH255950</bold></td><td align="center" rowspan="1" colspan="1">MVs/Olamze.CMR/2.13/</td><td align="center" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">South- Olamze</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255951</bold></td><td align="center" rowspan="1" colspan="1">MVs/Garoua Boulai.CMR/10.13/</td><td align="center" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">East-Garoua Boulai</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255952</bold></td><td align="center" rowspan="1" colspan="1">MVs/Loum.CMR/14.13/</td><td align="center" rowspan="1" colspan="1">72</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">Littoral-Loum</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255953</bold></td><td align="center" rowspan="1" colspan="1">MVs/Citee des Palmiers.CMR/25.13/</td><td align="center" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">Littoral-Citee des Palmiers</td><td align="center" rowspan="1" colspan="1">15/05/2013</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255954</bold></td><td align="center" rowspan="1" colspan="1">MVs/Olamze.CMR/5.13/</td><td align="center" rowspan="1" colspan="1">156</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">South- Olamze</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255955</bold></td><td align="center" rowspan="1" colspan="1">MVs/Mifi.CMR/7.13/</td><td align="center" rowspan="1" colspan="1">72</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">West-Mifi</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255956</bold></td><td align="center" rowspan="1" colspan="1">MVs/Foumbot.CMR/7.13/</td><td align="center" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">West-Foumbot</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255957</bold></td><td align="center" rowspan="1" colspan="1">MVs/Foumbot.CMR/6.13/</td><td align="center" rowspan="1" colspan="1">144</td><td align="left" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">West-Foumbot</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255958</bold></td><td align="center" rowspan="1" colspan="1">MVs/Maroua Rural.CMR/8.14/</td><td align="center" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">Far Norht-Maroua Rural</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255959</bold></td><td align="center" rowspan="1" colspan="1">MVs/Yoko.CMR/9.14/</td><td align="center" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">Centre-Yoko</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255960</bold></td><td align="center" rowspan="1" colspan="1">MVs/Mbouda.CMR/10.14/2/</td><td align="center" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">West-Mbouda</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255961</bold></td><td align="center" rowspan="1" colspan="1">MVs/Mbouda.CMR/10.14/</td><td align="center" rowspan="1" colspan="1">72</td><td align="left" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">West-Mbouda</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255962</bold></td><td align="center" rowspan="1" colspan="1">MVs/Bibemi.CMR/10.14/</td><td align="center" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">North-Bibemi</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255963</bold></td><td align="center" rowspan="1" colspan="1">MVs/Foundong.CMR/9.14/</td><td align="center" rowspan="1" colspan="1">48</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">North West-Fundong</td><td align="center" rowspan="1" colspan="1">14/09/2010</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255964</bold></td><td align="center" rowspan="1" colspan="1">MVs/Maroua Urbain.CMR/11.14/</td><td align="center" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">Far North-Maroua Urbain</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255965</bold></td><td align="center" rowspan="1" colspan="1">MVs/Maroua Urbain/11.14/2/</td><td align="center" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">Far North-Maroua Urbain</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255966</bold></td><td align="center" rowspan="1" colspan="1">MVs/Maroua Urbain.CMR/11.14/3/</td><td align="center" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">Far North-Maroua Urbain</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255967</bold></td><td align="center" rowspan="1" colspan="1">MVs/Kumba.CMR/26.14/</td><td align="center" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">South West-Kumba</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255968</bold></td><td align="center" rowspan="1" colspan="1">MVs/Betare Oya.CMR/38.14/</td><td align="center" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">East-Betare Oya</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255969</bold></td><td align="center" rowspan="1" colspan="1">MVs/Betare Oya.CMR/38.14/2/</td><td align="center" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">East-Betare Oya</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255970</bold></td><td align="center" rowspan="1" colspan="1">MVs/Betare Oya.CMR/38.14/3/</td><td align="center" rowspan="1" colspan="1">96</td><td align="left" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">East-Betare Oya</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255971</bold></td><td align="center" rowspan="1" colspan="1">MVs/Kumba.CMR/43.14/</td><td align="center" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">South West-Kumba</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255972</bold></td><td align="center" rowspan="1" colspan="1">MVs/Ngaoundere Rural.CMR/46.14/</td><td align="center" rowspan="1" colspan="1">168</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">Adamawa-Ngaoundere Rural</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255973</bold></td><td align="center" rowspan="1" colspan="1">MVs/Touboro.CMR/46.14/</td><td align="center" rowspan="1" colspan="1">240</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">North-Touboro</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255974</bold></td><td align="center" rowspan="1" colspan="1">MVs/Bertoua.CMR/51.14/</td><td align="center" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">East-Bertoua</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255975</bold></td><td align="center" rowspan="1" colspan="1">MVs/Nwa.CMR/3.14/</td><td align="center" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">North West-Nwa</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255976</bold></td><td align="center" rowspan="1" colspan="1">MVs/Nwa.CMR/3.14/2/</td><td align="center" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">North West-Nwa</td><td align="center" rowspan="1" colspan="1">01/02/2009</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255977</bold></td><td align="center" rowspan="1" colspan="1">MVs/Garoua Boulai.CMR/8.14/</td><td align="center" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">East-Garoua Boulai</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255978</bold></td><td align="center" rowspan="1" colspan="1">MVs/Guidiguis.CMR/3.15/</td><td align="center" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">Far North-Guidiguis</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255979</bold></td><td align="center" rowspan="1" colspan="1">MVs/Guidiguis.CMR/3.15/2/</td><td align="center" rowspan="1" colspan="1">84</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">Far North-Guidiguis</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255980</bold></td><td align="center" rowspan="1" colspan="1">MVs/Biyem Assi.CMR/8.15/</td><td align="center" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">Centre-Biyem Assi</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255981</bold></td><td align="center" rowspan="1" colspan="1">MVs/Yokadouma.CMR/8.15/</td><td align="center" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">East-Yokadouma</td><td align="center" rowspan="1" colspan="1">21/10/2012</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255982</bold></td><td align="center" rowspan="1" colspan="1">MVs/Kumba.CMR/18.15/</td><td align="center" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">South West-Kumba</td><td align="center" rowspan="1" colspan="1">01/11/2012</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255983</bold></td><td align="center" rowspan="1" colspan="1">MVs/Lagdo.CMR/10.16/</td><td align="center" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">North-Lagdo</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255984</bold></td><td align="center" rowspan="1" colspan="1">MVs/Lagdo.CMR/12.16/</td><td align="center" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">North-Lagdo</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255985</bold></td><td align="center" rowspan="1" colspan="1">MVs/Kumba.CMR/18.16/</td><td align="center" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">South West-Kumba</td><td align="center" rowspan="1" colspan="1">02/02/2015</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255986</bold></td><td align="center" rowspan="1" colspan="1">MVs/Zoetele.CMR/38.16/2/</td><td align="center" rowspan="1" colspan="1">168</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">South-Zoetele</td><td align="center" rowspan="1" colspan="1">01/02/2003</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255987</bold></td><td align="center" rowspan="1" colspan="1">MVs/Zoetele.CMR/38.16/</td><td align="center" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">South-Zoetele</td><td align="center" rowspan="1" colspan="1">01/12/2013</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255988</bold></td><td align="center" rowspan="1" colspan="1">MVs/Mora.CMR/45.16/</td><td align="center" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">Far North-Mora</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>MH255989</bold></td><td align="center" rowspan="1" colspan="1">MVs/Bertoua.CMR/7.16/</td><td align="center" rowspan="1" colspan="1">108</td><td align="left" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">East-Bertoua</td><td align="center" rowspan="1" colspan="1"/></tr></tbody></table></alternatives></table-wrap><p>The sequences obtained came from all regions of Cameroon: 01 from Adamawa, 02 from the Center, 08 from the East, 07 from the Far North, 02 from the Littoral, 04 from the North, 03 from the North West, 04 from the South, 04 from the South West and 05 from the West (<xref ref-type="fig" rid="pone.0222428.g001">Fig 1</xref>, <xref rid="pone.0222428.t001" ref-type="table">Table 1</xref>).</p><fig id="pone.0222428.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0222428.g001</object-id><label>Fig 1</label><caption><title>Distribution of genotype B3.1.</title><p>Strains by region and year of collection diamonds (&#x02666;) represent the viruses collected in 2013, triangles (&#x025b2;) for those collected in 2014, black circles (&#x025cf;) for viruses collected in 2015 and white circles (&#x025cb;) for those collected in 2016.</p></caption><graphic xlink:href="pone.0222428.g001"/></fig><p>Phylogenetic analyses showed that all sequences obtained in this study clustered with the MVi/Ibadan.NGA/0.97/1 genotype B3 sequence with a bootstrap value greater than 90% (<xref ref-type="fig" rid="pone.0222428.g002">Fig 2</xref>). A phylogenetic tree of the sub-group to which the Cameroon strains belong is shown in <xref ref-type="fig" rid="pone.0222428.g003">Fig 3</xref>. All strains belonged to cluster B3.1 with a bootstrap value greater than 90%.</p><fig id="pone.0222428.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0222428.g002</object-id><label>Fig 2</label><caption><title>Phylogenetic tree of sequences studied with reference sequences.</title><p> The studied sequences are in bold and represented by a black triangle, the reference sequences are demarked with the genotype between hooks. Accession numbers and virus names are included on the tree. Phylogenetic analysis was performed based on 450 nucleotides of the N gene in MEGA version 7.0. Evolutionary history was inferred using the Maximum Likelihood method and distances were computed using the Kimura two-parameter model. The bootstrap test was set to 1000 replicates and bootstrap values above 70% are shown next to the main tree branches.</p></caption><graphic xlink:href="pone.0222428.g002"/></fig><fig id="pone.0222428.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0222428.g003</object-id><label>Fig 3</label><caption><title>Sub genotyping phylogenetic tree.</title><p> The studied sequences are represented by a black triangle. The tree was rooted with a sequence belonging to genotype D2. Accession numbers and virus names are included on the tree. Phylogenetic analysis was performed based on 450 nucleotides of the N gene in MEGA version 7.0. Evolutionary history was inferred using the Maximum Likelihood method and distances were computed using the Kimura-two parameter model. The bootstrap test was set to 1000 replicates and bootstrap values above 70% are shown next to the main tree branches.</p></caption><graphic xlink:href="pone.0222428.g003"/></fig></sec><sec sec-type="conclusions" id="sec008"><title>Discussion</title><p>Cameroon integrated measles surveillance in 1974 through sentinel sites in the city of Yaound&#x000e9; [<xref rid="pone.0222428.ref018" ref-type="bibr">18</xref>]. The first genetic data on MeV date from 1994 with the identification of genotype B1 strain <italic>Yaounde</italic>.<italic>CAE/12</italic>.<italic>83 "Y-14"</italic> in Yaound&#x000e9; [<xref rid="pone.0222428.ref014" ref-type="bibr">14</xref>]. Virological surveillance of MeV strains in Cameroon was effectively implemented in 2011 at the National Measles Laboratory [<xref rid="pone.0222428.ref016" ref-type="bibr">16</xref>]. This study is the fourth to investigate MeV strains circulating in Cameroon [<xref rid="pone.0222428.ref014" ref-type="bibr">14</xref>&#x02013;<xref rid="pone.0222428.ref016" ref-type="bibr">16</xref>] and the second from the virological surveillance program set up in 2011.</p><p>The results show that the average age of the affected subjects is 8.6 years with extremes of 7 months and 20 years, suggesting that, measles remains a disease of children and young adults regardless of gender [<xref rid="pone.0222428.ref019" ref-type="bibr">19</xref>].</p><p>According to the phylogenetic analyses, all the sequences from Cameroon belonged to cluster 1 of genotype B3. The same cluster was detected in Cameroon in 2001 and from 2010 to 2011 [<xref rid="pone.0222428.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0222428.ref016" ref-type="bibr">16</xref>]; in Nigeria and Ghana in 1998 [<xref rid="pone.0222428.ref020" ref-type="bibr">20</xref>]; in Sudan from 1997 to 2000 [<xref rid="pone.0222428.ref021" ref-type="bibr">21</xref>]; and in the Central African Republic in 2000 [<xref rid="pone.0222428.ref022" ref-type="bibr">22</xref>]. Cluster B3.1 strains remain endemic in Cameroon, where they have been circulating for about 17 years. This study is the first to characterize the MeV strains among Cameroonians in Adamawa, East and South regions. The East region borders the Central African Republic by Garoua Boulai and Betare Oya health districts and the South region borders Gabon and Equatorial Guinea by Olamze health district. Although there is no evidence of imported MeV strains in this study, the possibility of cross-contamination between Cameroonian populations and those bordering them is not excluded as the same genotype (B3) circulates in almost all of sub-Saharan Africa [<xref rid="pone.0222428.ref021" ref-type="bibr">21</xref>]. A previous study reported the circulation of this same genotype in the East region of Cameroon though it was among refugees from Central African Republic [<xref rid="pone.0222428.ref023" ref-type="bibr">23</xref>].</p><p>A small subset of the population (20%) from whom the samples were collected were vaccinated but no vaccine strain was detected. Keeping in mind that in Cameroon the first dose of measles-containing vaccine (MCV1) is administered at the age of 9 months [<xref rid="pone.0222428.ref024" ref-type="bibr">24</xref>], the patient in whom the MeV strains were detected presented rash at varying periods between 1 month and 12 years following immunization. These results reflect vaccination failures in these individuals probably due to non-development of vaccine induced protective immunity in some individuals, non-compliance to the CDC recommendations for uptake of two vaccine doses [<xref rid="pone.0222428.ref025" ref-type="bibr">25</xref>] or a poor conditioning of the vaccines [<xref rid="pone.0222428.ref026" ref-type="bibr">26</xref>].</p><p>The exclusive presence of cluster B3.1 strains in this study indicates the possible elimination of cluster B3.3 from Cameroon which was identified to circulate between 2010 and 2011 in the Far North and in the Centre regions. This suggests that, efforts made by the country for elimination of the disease are effective though should be re-enforced as the B3.1 genotype has been in circulation for over 17 years. Efforts should be put on childhood immunization since most affected children are not immunized. A second vaccine dose must as well be introduced into routine childhood immunization [<xref rid="pone.0222428.ref013" ref-type="bibr">13</xref>] which will allow the catch-up of failures of the first dose for a better follow-up of the recommendations for control and elimination of measles as proposed by WHO.</p><p>The study provided recent data on circulating measles viral strains throughout the country as the incidence of measles has increased worldwide. The limits of this work were the impossibility to completely sequence the studied genomes and the presence of limited samples in some years.</p></sec></body><back><ack><p>We would like to acknowledge the Cameroon health districts for collecting samples and the Expanded Program of Immunization for collaboration in the transport of samples to the laboratory. We also want to thank the Pasteur Institute in Paris for supporting in sequencing the samples.</p></ack><ref-list><title>References</title><ref id="pone.0222428.ref001"><label>1</label><mixed-citation publication-type="book"><name><surname>Griffin</surname><given-names>DE</given-names></name>. <chapter-title>Measles virus</chapter-title>
<source>Fields Virology</source>: <volume>Volume 1</volume>
<publisher-name>Wolters Kluwer Health Adis (ESP)</publisher-name>; <year>2007</year> pp. <fpage>1551</fpage>&#x02013;<lpage>1585</lpage>. <ext-link ext-link-type="uri" xlink:href="https://jhu.pure.elsevier.com/en/publications/measles-virus">https://jhu.pure.elsevier.com/en/publications/measles-virus</ext-link></mixed-citation></ref><ref id="pone.0222428.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Alla</surname><given-names>A</given-names></name>, <name><surname>Waku-Kouomou</surname><given-names>D</given-names></name>, <name><surname>Benjouad</surname><given-names>A</given-names></name>, <name><surname>Elaouad</surname><given-names>R</given-names></name>, <name><surname>Wild</surname><given-names>TF</given-names></name>. <article-title>Rapid diversification of measles virus genotypes circulating in Morocco during 2004&#x02013;2005 epidemics</article-title>. <source>J Med Virol</source>. <year>2006</year>;<volume>78</volume>: <fpage>1465</fpage>&#x02013;<lpage>1472</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.20720</pub-id>
<?supplied-pmid 16998886?><pub-id pub-id-type="pmid">16998886</pub-id></mixed-citation></ref><ref id="pone.0222428.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Heymann</surname><given-names>DL</given-names></name>, <name><surname>Murphy</surname><given-names>KR</given-names></name>, <name><surname>Guyer</surname><given-names>B</given-names></name>, <name><surname>Foster</surname><given-names>SO</given-names></name>. <article-title>Organisation Coverage by Sample Survey</article-title>. <source>Yale J Biol Med</source>. <year>1979</year>; <fpage>1979</fpage>&#x02013;<lpage>1981</lpage>.</mixed-citation></ref><ref id="pone.0222428.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Mahamud</surname><given-names>A</given-names></name>, <name><surname>Burton</surname><given-names>A</given-names></name>, <name><surname>Hassan</surname><given-names>M</given-names></name>, <name><surname>Ahmed</surname><given-names>JA</given-names></name>, <name><surname>Wagacha</surname><given-names>JB</given-names></name>, <name><surname>Spiegel</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Risk factors for measles mortality among hospitalized Somali refugees displaced by famine, Kenya, 2011</article-title>. <source>Clin Infect Dis</source>. <year>2013</year>;<volume>57</volume>
<pub-id pub-id-type="doi">10.1093/cid/cit442</pub-id>
<?supplied-pmid 23821730?><pub-id pub-id-type="pmid">23821730</pub-id></mixed-citation></ref><ref id="pone.0222428.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Dabbagh</surname><given-names>A</given-names></name>, <name><surname>Patel</surname><given-names>MK</given-names></name>, <name><surname>Dumolard</surname><given-names>L</given-names></name>, <name><surname>Gacic-dobo</surname><given-names>M</given-names></name>, <name><surname>Mulders</surname><given-names>MN</given-names></name>, <name><surname>Kretsinger</surname><given-names>K</given-names></name>, <etal>et al</etal>
<source>Progress Toward Regional Measles Elimination&#x02014;Worldwide, 2000&#x02013;2016</source>. <year>2017</year>;<volume>66</volume>: <fpage>1148</fpage>&#x02013;<lpage>1153</lpage>.</mixed-citation></ref><ref id="pone.0222428.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Eom</surname><given-names>H</given-names></name>, <name><surname>Park</surname><given-names>Y</given-names></name>, <name><surname>Kim</surname><given-names>J</given-names></name>, <name><surname>Yang</surname><given-names>J-S</given-names></name>, <name><surname>Kang</surname><given-names>H</given-names></name>, <name><surname>Kim</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Occurrence of measles in a country with elimination status: Amplifying measles infection in hospitalized children due to imported virus</article-title>. <source>PLoS One</source>. <year>2018</year>;<volume>13</volume>: <fpage>e0188957</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0188957</pub-id>
<?supplied-pmid 29447169?><pub-id pub-id-type="pmid">29447169</pub-id></mixed-citation></ref><ref id="pone.0222428.ref007"><label>7</label><mixed-citation publication-type="other">Salvi C, Manager ER, Emergencies H, Diseases C, Negru L, Media C, et al. Europe observes a 4-fold increase in measles cases in 2017 compared to previous year. 2018; 2017&#x02013;2019.</mixed-citation></ref><ref id="pone.0222428.ref008"><label>8</label><mixed-citation publication-type="other">W.H.O. D of C of NTD. Weekly epidemiological record Relev&#x000e9; &#x000e9;pid&#x000e9;miologique hebdomadaire. 2016; 285&#x02013;296.</mixed-citation></ref><ref id="pone.0222428.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Haddad-Boubaker</surname><given-names>S</given-names></name>, <name><surname>Rezq</surname><given-names>M</given-names></name>, <name><surname>Smeo</surname><given-names>MN</given-names></name>, <name><surname>Ben Yahia</surname><given-names>A</given-names></name>, <name><surname>Abudher</surname><given-names>A</given-names></name>, <name><surname>Slim</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Genetic characterization of clade B measles viruses isolated in Tunisia and Libya 2002&#x02013;2009 and a proposed new subtype within the B3 genotype</article-title>. <source>Virus Res. Elsevier B.V.</source>; <year>2010</year>;<volume>153</volume>: <fpage>258</fpage>&#x02013;<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1016/j.virusres.2010.08.011</pub-id>
<?supplied-pmid 20728482?><pub-id pub-id-type="pmid">20728482</pub-id></mixed-citation></ref><ref id="pone.0222428.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Plan</surname><given-names>S</given-names></name>. <source>Global Measles and Rubella Strategic Plan</source>. <year>2012</year>; <volume>44</volume>.</mixed-citation></ref><ref id="pone.0222428.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Mulders</surname><given-names>MN</given-names></name>, <name><surname>Rota</surname><given-names>PA</given-names></name>, <name><surname>Icenogle</surname><given-names>JP</given-names></name>, <name><surname>Brown</surname><given-names>KE</given-names></name>, <name><surname>Takeda</surname><given-names>M</given-names></name>, <name><surname>Rey</surname><given-names>GJ</given-names></name>, <etal>et al</etal>
<article-title>Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010&#x02013;2015</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2016</year>;<volume>65</volume>: <fpage>438</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.mm6517a3</pub-id>
<?supplied-pmid 27148917?><pub-id pub-id-type="pmid">27148917</pub-id></mixed-citation></ref><ref id="pone.0222428.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Rota</surname><given-names>PA</given-names></name>, <name><surname>Bellini</surname><given-names>WJ</given-names></name>. <article-title>Update on the global distribution of genotypes of wild type measles viruses</article-title>. <source>J Infect Dis</source>. <year>2003</year>;<volume>187</volume>
<issue>Suppl</issue>: <fpage>S270-6</fpage>
<pub-id pub-id-type="doi">10.1086/368042</pub-id>
<?supplied-pmid 12721925?><pub-id pub-id-type="pmid">12721925</pub-id></mixed-citation></ref><ref id="pone.0222428.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Patel</surname><given-names>MK</given-names></name>, <name><surname>Gacic-dobo</surname><given-names>M</given-names></name>, <name><surname>Strebel</surname><given-names>PM</given-names></name>, <name><surname>Dabbagh</surname><given-names>A</given-names></name>, <name><surname>Mulders</surname><given-names>MN</given-names></name>. <source>Progress Toward Regional Measles Elimination&#x02014;Worldwide, 2000&#x02013;2015</source>. <year>2016</year>;<volume>65</volume>: <fpage>1228</fpage>&#x02013;<lpage>1233</lpage>.</mixed-citation></ref><ref id="pone.0222428.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Rota</surname><given-names>PA</given-names></name>, <name><surname>Bloom</surname><given-names>AE</given-names></name>, <name><surname>Vanchiere</surname><given-names>JA</given-names></name>, <name><surname>Bellini</surname><given-names>WJ</given-names></name>. <article-title>Evolution of the Nucleoprotein and Matrix Genes of Wild-Type Strains of Measles Virus Isolated from Recent Epidemics</article-title>. <source>Virology</source>. <year>1994</year> pp. <fpage>724</fpage>&#x02013;<lpage>730</lpage>. <pub-id pub-id-type="doi">10.1006/viro.1994.1086</pub-id>
<?supplied-pmid 8291252?><pub-id pub-id-type="pmid">8291252</pub-id></mixed-citation></ref><ref id="pone.0222428.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Waku Kouomou</surname><given-names>D</given-names></name>, <name><surname>Nerrienet</surname><given-names>E</given-names></name>, <name><surname>Mfoupouendoun</surname><given-names>J</given-names></name>, <name><surname>Tene</surname><given-names>G</given-names></name>, <name><surname>Whittle</surname><given-names>H</given-names></name>, <name><surname>Wild</surname><given-names>TF</given-names></name>. <article-title>Measles virus strains circulating in Central and West Africa: Geographical distribution of two B3 genotypes</article-title>. <source>J Med Virol</source>. <year>2002</year>;<volume>68</volume>: <fpage>433</fpage>&#x02013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.10222</pub-id>
<?supplied-pmid 12226833?><pub-id pub-id-type="pmid">12226833</pub-id></mixed-citation></ref><ref id="pone.0222428.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Demanou</surname><given-names>M</given-names></name>, <name><surname>Ratsitoharana</surname><given-names>R</given-names></name>, <name><surname>Yonga</surname><given-names>M</given-names></name>, <name><surname>Dosseh</surname><given-names>A</given-names></name>, <name><surname>Anya</surname><given-names>B</given-names></name>, <name><surname>Kobela</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Molecular characterization of measles viruses that circulated in Cameroon between 2010 and 2011</article-title>. <source>Virol J. Virology Journal</source>; <year>2013</year>;<volume>10</volume>: <fpage>1</fpage>.<pub-id pub-id-type="pmid">23279912</pub-id></mixed-citation></ref><ref id="pone.0222428.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Focus</surname><given-names>E</given-names></name>. <article-title>WHO: Weekly epidemiological record Relev&#x000e9; &#x000e9;pid&#x000e9;miologique hebdomadaire</article-title>. <source>Wkly Epidemiol Rec</source>. <year>2016</year>;<volume>21</volume>: <fpage>265</fpage>&#x02013;<lpage>284</lpage>.</mixed-citation></ref><ref id="pone.0222428.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Heymann</surname><given-names>DL</given-names></name>, <name><surname>Murphy</surname><given-names>KR</given-names></name>, <name><surname>Kesseng Mayben</surname><given-names>G</given-names></name>, <name><surname>Guyer</surname><given-names>B</given-names></name>, <name><surname>Foster</surname><given-names>SO</given-names></name>. <article-title>MEASLES CONTROL IN YAOUNDE: JUSTIFICATION OF A ONE DOSE, NINE MONTH MINIMUM AGE VACCINATION POLICY IN TROPICAL AFRICA</article-title>. <source>Lancet. Elsevier</source>; <year>1983</year>;<volume>322</volume>: <fpage>1470</fpage>&#x02013;<lpage>1472</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(83)90813-9</pub-id></mixed-citation></ref><ref id="pone.0222428.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Delaporte</surname><given-names>E</given-names></name>, <name><surname>Siegrist</surname><given-names>C</given-names></name>, <name><surname>Wyler</surname><given-names>CA</given-names></name>, <name><surname>Gervaix</surname><given-names>A</given-names></name>. <article-title>Rougeole&#x0202f;: diagnostic et prise en charge d&#x02019;une maladie toujours d&#x02019;actualit&#x000e9;</article-title>. <source>Rev Med Suisse</source>. <year>2008</year>;<volume>19</volume>: <fpage>920</fpage>&#x02013;<lpage>924</lpage>.</mixed-citation></ref><ref id="pone.0222428.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Hanses</surname><given-names>F</given-names></name>, <name><surname>Truong</surname><given-names>AT</given-names></name>, <name><surname>Ammerlaan</surname><given-names>W</given-names></name>, <name><surname>Ikusika</surname><given-names>O</given-names></name>, <name><surname>Adu</surname><given-names>F</given-names></name>, <name><surname>Oyefolu</surname><given-names>AO</given-names></name>, <etal>et al</etal>
<article-title>Molecular epidemiology of Nigerian and Ghanaian measles virus isolates reveals a genotype circulating widely in western and central Africa</article-title>. <source>J Gen Virol</source>. <year>1999</year>;<volume>80</volume>: <fpage>871</fpage>&#x02013;<lpage>877</lpage>. <pub-id pub-id-type="doi">10.1099/0022-1317-80-4-871</pub-id>
<?supplied-pmid 10211955?><pub-id pub-id-type="pmid">10211955</pub-id></mixed-citation></ref><ref id="pone.0222428.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>El Mubarak</surname><given-names>HS</given-names></name>
<name><surname>Van De Bildt</surname><given-names>MWG</given-names></name>, <name><surname>Mustafa</surname><given-names>OA</given-names></name>
<name><surname>Vos</surname><given-names>HW</given-names></name>, <name><surname>Mukhtar</surname><given-names>MM</given-names></name>
<name><surname>Ibrahim</surname><given-names>SA</given-names></name>, <etal>et al</etal>
<article-title>Genetic characterization of wild-type measles viruses circulating in suburban Khartoum, 1997&#x02013;2000</article-title>. <source>J Gen Virol</source>. <year>2002</year>;<volume>83</volume>: <fpage>1437</fpage>&#x02013;<lpage>1443</lpage>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.microbiologyresearch.org/docserver/fulltext/jgv/83/6/0831437a.pdf?expires=1525683365&#x00026;id=id&#x00026;accname=guest&#x00026;checksum=2B0AEC8A352C143F908E0875A0286248">http://www.microbiologyresearch.org/docserver/fulltext/jgv/83/6/0831437a.pdf?expires=1525683365&#x00026;id=id&#x00026;accname=guest&#x00026;checksum=2B0AEC8A352C143F908E0875A0286248</ext-link>
<?supplied-pmid 12029159?><pub-id pub-id-type="pmid">12029159</pub-id></mixed-citation></ref><ref id="pone.0222428.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Gouandjika-Vasilache</surname><given-names>I</given-names></name>, <name><surname>Waku-Kouomou</surname><given-names>D</given-names></name>, <name><surname>M&#x000e9;</surname><given-names>D</given-names></name>, <name><surname>Beyrand</surname><given-names>C</given-names></name>, <name><surname>Guye</surname><given-names>F</given-names></name>, <name><surname>Ngoay-Kossy</surname><given-names>JC</given-names></name>, <etal>et al</etal>
<article-title>Cocirculation of Measles Virus Genotype B2 and B3.1 in Central African Republic During the 2000 Measles Epidemic</article-title>. <source>J Med Virol J Med Virol</source>. <year>2006</year>;<volume>78</volume>
<pub-id pub-id-type="doi">10.1002/jmv.20648</pub-id>
<?supplied-pmid 16721862?><pub-id pub-id-type="pmid">16721862</pub-id></mixed-citation></ref><ref id="pone.0222428.ref023"><label>23</label><mixed-citation publication-type="other">Ndombo PK, Ndze VN, Mbarga FD, Anderson R, Acho A, Ebua J, et al. Molecular characterisation of measles virus strains among refugees from Central African Republic in Cameroon in 2014. 2018;</mixed-citation></ref><ref id="pone.0222428.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Gateff</surname><given-names>C</given-names></name>. <article-title>Evaluation of a mass measles immunization campaign in yaound&#x000e9;, cameroun</article-title>. <source>Trans R Soc Trop Med Hyg</source>. <year>1976</year>;<volume>70</volume>: <fpage>206</fpage>&#x02013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1016/0035-9203(76)90040-7</pub-id>
<?supplied-pmid 982514?><pub-id pub-id-type="pmid">982514</pub-id></mixed-citation></ref><ref id="pone.0222428.ref025"><label>25</label><mixed-citation publication-type="other">MMR Vaccination | What You Should Know | Measles, Mumps, Rubella | CDC [Internet]. [cited 9 May 2019]. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/vaccines/vpd/mmr/public/index.html">https://www.cdc.gov/vaccines/vpd/mmr/public/index.html</ext-link></mixed-citation></ref><ref id="pone.0222428.ref026"><label>26</label><mixed-citation publication-type="other">Secondary failure rates of measles vaccines: a metaanalysis &#x02026;&#x0202f;: The Pediatric Infectious Disease Journal [Internet]. [cited 29 Mar 2018]. <ext-link ext-link-type="uri" xlink:href="https://journals.lww.com/pidj/Abstract/1996/01000/Secondary_failure_rates_of_measles_vaccines__a.14.aspx">https://journals.lww.com/pidj/Abstract/1996/01000/Secondary_failure_rates_of_measles_vaccines__a.14.aspx</ext-link></mixed-citation></ref></ref-list></back></article>